Money Concepts Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Money Concepts Capital’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$488K	Sell	3,083 -239	-7%	-$32.3K	0.02%	420
2026 Q1	$424K	Buy	3,322 +366	+12%	+$45.7K	0.02%	402
2025 Q4	$360K	Buy	2,956 +797	+37%	+$91.4K	0.02%	398
2025 Q3	$216K	Buy	+2,159	New	+$194K	0.01%	444
2025 Q1	–	Sell	-245,148	Closed	-$22.1M	–	445
2024 Q4	$22.1M	Buy	245,148 +13,875	+6%	+$1.34M	1.64%	12
2024 Q3	$22.8M	Buy	231,273 +62,098	+37%	+$6.1M	1.73%	11
2024 Q2	$15.7M	Buy	169,175 +26,198	+18%	+$2.35M	1.32%	16
2024 Q1	$13.6M	Buy	+142,977	New	+$13.3M	1.25%	15
2023 Q2	–	Sell	-70,832	Closed	-$1.39M	–	499
2023 Q1	$1.39M	Buy	70,832 +64,640	+1,044%	+$5.36M	0.08%	177
2022 Q4	$514K	Buy	6,192 +4,435	+252%	+$359K	0.02%	426
2022 Q3	$139K	Sell	1,757 -1,022	-37%	-$86.2K	0.01%	497
2022 Q2	$213K	Sell	2,779 -7,908	-74%	-$594K	0.02%	400
2022 Q1	$961K	Buy	10,687 +7,856	+277%	+$725K	0.05%	306
2021 Q4	$317K	Buy	+2,831	New	+$341K	0.03%	398
2021 Q1	$518K	Sell	3,815 -4,544	-54%	-$680K	0.04%	308
2020 Q4	$1.18M	Buy	+8,359	New	+$1.07M	0.11%	166

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Money Concepts Capital's XBI Position: Q2 2026 in Review

Money Concepts Capital reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 7.2% in Q2 2026, selling an estimated $32.3K and leaving 3,083 shares worth $488K. The position accounts for 0.02% of the portfolio, ranked #420.

Money Concepts Capital first reported a position in XBI in Q4 2020 and has held it in 16 quarters since. The position peaked at $22.8M in Q3 2024. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Money Concepts Capital held 3,083 shares of State Street SPDR S&P Biotech ETF worth $488K as of Q2 2026.
Money Concepts Capital sold 239 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $32.3K.
State Street SPDR S&P Biotech ETF made up 0.02% of Money Concepts Capital's portfolio in Q2 2026, its #420 holding.
Money Concepts Capital first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and has held it in 16 quarters since.
Money Concepts Capital's State Street SPDR S&P Biotech ETF position peaked at $22.8M in Q3 2024.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Money Concepts Capital's 13F filing for Q2 2026, filed 4 Aug 2026.